Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Elad Shemesh & Barak Zafrir. (2019) Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks. Diabetes, Metabolic Syndrome and Obesity 12, pages 2041-2052.
Read now
Read now
David Rhainds, Mathieu R. Brodeur & Jean-Claude Tardif. (2019) Investigational drugs in development for hypertriglyceridemia: a coming-of-age story. Expert Opinion on Investigational Drugs 28:12, pages 1059-1079.
Read now
Read now
Etienne Khoury, Diane Brisson, Nathalie Roy, Gérald Tremblay & Daniel Gaudet. (2019) Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemia. Expert Opinion on Drug Safety 18:5, pages 403-414.
Read now
Read now
Articles from other publishers (16)
Mingyu Zhang, Taoyuan Yin, Feng Xia, Suhong Xia, Wangdong Zhou, Yu Zhang, Xu Han, Kai Zhao, Lina Feng, Ruonan Dong, Dean Tian, Yan Yu & Jiazhi Liao. (2022) Hypertriglyceridemia may contribute to stroke and pancreatitis: A case report and review of the literature. Frontiers in Endocrinology 13.
Crossref
Crossref
Yangmin Zheng, Yue Hu, Ziping Han, Feng Yan, Sijia Zhang, Zhenhong Yang, Fangfang Zhao, Lingzhi Li, Junfen Fan, Rongliang Wang & Yumin Luo. (2022) Lomitapide ameliorates middle cerebral artery occlusion‐induced cerebral ischemia/reperfusion injury by promoting neuronal autophagy and inhibiting microglial migration. CNS Neuroscience & Therapeutics 28:12, pages 2183-2194.
Crossref
Crossref
Amanda J Berberich & Robert A Hegele. (2022) A Modern Approach to Dyslipidemia. Endocrine Reviews 43:4, pages 611-653.
Crossref
Crossref
Isabel Shamsudeen & Robert A. Hegele. (2022) Advances in the care of lipodystrophies. Current Opinion in Endocrinology, Diabetes & Obesity 29:2, pages 152-160.
Crossref
Crossref
Jun-Shang Huang, Bin-Bin Guo, Fei-Fei Lin, Li-Min Zeng, Ting Wang, Xiang-Yu Dang, Yang Yang, You-Hong Hu, Jia Liu & He-Yao Wang. (2021) A novel low systemic diacylglycerol acyltransferase 1 inhibitor, Yhhu2407, improves lipid metabolism. European Journal of Pharmaceutical Sciences 158, pages 105683.
Crossref
Crossref
Angelo B. Cefalù, Antonina Giammanco, Davide Noto, Rossella Spina, Daniela Cabibi, Carlo M. Barbagallo & Maurizio Averna. (2020) Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndrome. Endocrine 71:2, pages 344-350.
Crossref
Crossref
Alan S. Brown, Ehab G. Dababneh, Adib Chaus, Vadzim Chyzhyk, Victor Marinescu & Nataliya Pyslar. 2021. Therapeutic Lipidology. Therapeutic Lipidology
35
80
.
Antonio Gallo, Sophie Béliard, Laura D’Erasmo & Eric Bruckert. (2020) Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment. Current Atherosclerosis Reports 22:11.
Crossref
Crossref
Juan Pedro-Botet, Juan F. Ascaso, Mariano Blasco, Ángel Brea, Ángel Díaz, Antonio Hernández-Mijares, Xavier Pintó & Jesús Millán. (2020) Triglicéridos, colesterol HDL y dislipidemia aterogénica en la guía europea para el control de las dislipidemias 2019. Clínica e Investigación en Arteriosclerosis 32:5, pages 209-218.
Crossref
Crossref
Juan Pedro-Botet, Juan F. Ascaso, Mariano Blasco, Ángel Brea, Ángel Díaz, Antonio Hernández-Mijares, Xavier Pintó & Jesús Millán. (2020) Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias. Clínica e Investigación en Arteriosclerosis (English Edition) 32:5, pages 209-218.
Crossref
Crossref
Antonina Giammanco, Angelo B. Cefalù, Davide Noto & Maurizio R. Averna. (2020) Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide. Current Medicinal Chemistry 27:23, pages 3773-3783.
Crossref
Crossref
Vadzim Chyzhyk & Alan S. Brown. (2020) Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis. Trends in Cardiovascular Medicine 30:2, pages 80-85.
Crossref
Crossref
Julieta Lazarte & Robert A. Hegele. (2020) Dyslipidemia Management in Adults With Diabetes. Canadian Journal of Diabetes 44:1, pages 53-60.
Crossref
Crossref
Latifah Alothman & Jacques Genest. (2019) Chylomicrons: When you can't direct the wind, adjust the sail. Atherosclerosis 283, pages 121-123.
Crossref
Crossref
Anthony C. Keech & Alicia J. Jenkins. (2017) Triglyceride-lowering trials. Current Opinion in Lipidology 28:6, pages 477-487.
Crossref
Crossref
Xin Liu, Peng Men, Yuhui Wang, Suodi Zhai, Zhigang Zhao & George Liu. (2017) Efficacy and Safety of Lomitapide in Hypercholesterolemia. American Journal of Cardiovascular Drugs 17:4, pages 299-309.
Crossref
Crossref